Table 1.

Patient demographics, race, tumor subtype, and tumor histology.

			Total		Premenopausal (Age < 50)		Postmenopausal (Age ≥ 50)
			N = 4591		N = 902		N = 3689
Variable		n	Col%	n	Row%	n	Row%	p
Age at Diagnosis	18–39	221	4.8	221	100.0	0	0.0	<0.0001
	40–49	681	14.8	681	100.0	0	0.0
	50–59	993	21.6	0	0.0	993	100.0
	60–69	1398	30.5	0	0.0	1398	100.0
	70+	1298	28.3	0	0.0	1298	100.0
Race	White	979	21.3	190	19.4	789	80.6	0.5
	Asian	1799	39.2	319	17.7	1480	82.3
	Filipino	815	17.8	179	22.0	636	78.0
	NHPI	909	19.8	193	21.2	716	78.8
	other	89	1.9	21	23.6	68	76.4
Subtype	Triple Positive	242	5.3	74	30.6	168	69.4	<0.0001
	HR+ HER2−	3746	81.6	682	18.2	3064	81.8
	HR− HER2+	188	4.1	54	28.7	134	71.3
	Triple Negative	415	9.0	92	22.2	323	77.8
Histology	Ductal	3873	84.4	790	20.4	3083	79.6	0.15
	Lobular	434	9.5	66	15.2	368	84.8
	Mucinous	153	3.3	26	17.0	127	83.0
	Tubular	12	0.3	2	16.7	10	83.3
	Metaplastic	15	0.3	3	20.0	12	80.0
	Mixed	23	0.5	4	17.4	19	82.6
	other	81	1.8	11	13.6	70	86.4
County	Hawai’i	96	2.1	31	32.3	65	67.7	0.01
	Honolulu	2213	48.2	447	20.2	1766	79.8
	Kauai	352	7.7	58	16.5	294	83.5
	Maui	136	3.0	24	17.6	112	82.4
	unknown	1794	39.1	342	19.1	1452	80.9
Year	2015	685	14.9	134	19.6	551	80.4	0.53
	2016	672	14.6	117	17.4	555	82.6
	2017	756	16.5	140	18.5	616	81.5
	2018	714	15.6	139	19.5	575	80.5
	2019	628	13.7	128	20.4	500	79.6
	2020	430	9.4	96	22.3	334	77.7
	2021	400	8.7	87	21.8	313	78.3
	2022	306	6.7	61	19.9	245	80.1